Tg Sanità, edition of 20 May 2024
We talk about dengue, gender dysphoria, motherhood and celiac disease
GENDER DYSPHORIA. TECHNICAL TABLE ESTABLISHED AT THE MINISTRY OF HEALTH
A technical table has been set up at the Ministry of Health to study the treatment of gender dysphoria. The Minister of Health, Orazio Schillaci, and the head of the Family Department, Eugenia Roccella, signed the decree. The table is made up of a pool of 29 experts, including officials from the two ministries and members of various scientific societies. The table, we read in the decree, was necessary considering the “non-homogeneity with which professionals operate in the national territory” and, consequently, the need to “have guidelines that support them in the complex path”.
DENGUE. ISS: 197 CASES CONFIRMED IN ITALY SINCE JANUARY, ALL ASSOCIATED WITH FOREIGN TRAVEL
The cases of confirmed dengue virus infection reported to the Istituto Superiore di Sanità from the beginning of the year to 13 May 2024 have risen to 197. No deaths have been reported. All reported cases were contracted while traveling abroad. Most of the infections were contracted in Brazil, one of the countries most affected by the dengue epidemic. “The local transmission of dengue in Italy, as well as in other European countries, is a rare event – comments Anna Teresa Palamara, who directs the Infectious Diseases department of the ISS – The majority of cases are contracted abroad, however the conditions climatic conditions and the presence of a mosquito capable of transmitting the virus make transmission possible in some months of the year”.
MATERNITY. IVI: AFTER 42 YEARS THE PMA’S SUCCESS PERCENTAGE COLLAPSES
“In Pma the age factor is decisive: embryos obtained with oocytes from a 35-year-old woman reach a 70% success rate. This percentage drops significantly in women after the age of 42, who risk the pregnancy not being completed and degenerating into a late miscarriage.” This was stated by Professor Antonio Pellicer, one of the world’s leading experts on fertility issues, full professor of Obstetrics and Gynecology at the University of Valencia and founder of the Valencian Institute of Infertility specialized in assisted reproduction. “Not only has the average age of women having their first child increased – he continues – but also that of women who undergo Pma cycles after the age of 40, which has gone from 20.7% in 005 to 34% in 2022 ”.
CELIAC DISEASE. IN ITALY IT AFFECTS OVER 600 THOUSAND PEOPLE, 350 THOUSAND DON’T KNOW THEY HAVE IT
In Italy there are over 600 thousand people with celiac disease, but 350 thousand do not yet know they have it. A photograph, the one taken from an analysis conducted by the Bhave Institute, in collaboration with the health policy magazine Italian Health Policy Brief (IHPB), which confirms the underestimation in the perception of this chronic autoimmune disease. According to experts, it is therefore necessary to make the healthcare response “more homogeneous and efficient” in all Regions and raise the level of quality of life of celiac patients, while at the same time encouraging the identification of subjects not yet diagnosed.
RARE DISEASES. IN ITALY 20 THOUSAND PEOPLE WITH TYPE 1 NEUROFIBROMATOSIS
Neurofibromatosis type 1 is a rare genetic disease that affects one in 3 thousand people worldwide and which in Italy is estimated to involve around 20 thousand patients. The clinical signs are extremely variable and may include the appearance of café-au-lait spots, freckles of the neck and armpits, multiple cutaneous and subcutaneous neurofibromas, ocular, neurological and oncological complications. To raise awareness of this pathology, ‘We are infinite shades’ is launched. Beyond the signs of neurofibromatosis’, the information campaign promoted by the Ananas, Anf and Linfa associations – Let’s fight together against neurofibromatosis, in collaboration with Alexion, AstraZeneca Rare Disease.
MACULOPATHIES. CAMPAGNA ROCHE ARRIVES IN POTENZA ‘YOUR POINT OF VIEW COUNTS’
The first stage of the 2024 campaign ‘Your point of view matters – don’t let maculopathy stop you’ to raise awareness about maculopathy starts from Potenza. The initiative, presented in the Gregorio Inguscio room of the Palazzo della Regione Basilicata, is promoted by Roche Italia with the patronage of the Association of Patients with Ocular Diseases (APMO), the Macula Committee, Retina Italia ODV and the Italian Society of Ophthalmological Sciences (SISO). The objective is to highlight the unmet needs of patients and caregivers, highlighting crucial aspects such as maintaining an active social and working life and the importance of prevention as a fundamental tool for improving the quality of life of those living with this pathology.
GET VACCINATED AGAINST SHINGLES, LONGEVITAS FOUNDATION CAMPAIGN
Growing old, yes, but paying attention to your health through prevention. For this reason, the Longevitas Foundation is conducting an awareness campaign aimed at the over 65s. Among the primary tools in combating infectious diseases to which the elderly could be exposed are vaccines, including the one against the so-called shingles, as is was explained in Milan at the conference ‘Staying healthy thanks to vaccination prevention in adults: the example of the Herpes Zoster vaccine’. “We need to build awareness – said Eleonora Selvi, president of the Longevitas Foundation – to make it clear that the vaccine is a very important tool. Furthermore, the health service is helped, because what we avoid spending on prevention can be invested in everyone’s health”.< /p>
